Sign in
4

Changes in Ownership

IMPACT BIOMEDICAL INC. Filed Acc 0001493152-24-048576

Chief Executive Officer bought 1,050 shares at an average $2.61 ($2,739)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Heuszel Frank D Chief Executive Officer 2024-11-26 Purchase +550 $2.63 $1,444 95,844 D
Heuszel Frank D Chief Executive Officer 2024-11-26 Purchase +500 $2.59 $1,295 96,344 D
Open-market purchases · 1,050 sh · avg $2.61 · $2,739
Loading xslF345X05/ownership.xml…